Sellas Life Sciences Group Inc (SLS)
Operating Cash Flow (Statement)
-$28.42M
TTM · Period ending: · USD
SLS Operating Cash Flow (Statement)
Latest reported-$28.42Mperiod ending
Latest reported-$28.42Mperiod ending
SLS TTM Cash from Operations (-$6.05M → -$28.42M)
TTM operating cash flow (statement)
High-resolution chart · PNG
SLS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -28,423,000 | |
| -28,165,000 | |
| -28,389,000 | |
| -30,621,000 | |
| -31,359,000 | |
| -33,711,000 | |
| -35,402,000 | |
| -33,074,000 | |
| -32,160,000 | |
| -30,044,000 | |
| -31,410,000 | |
| -31,737,000 | |
| -30,591,000 | |
| -28,786,000 | |
| -23,809,000 | |
| -23,633,000 | |
| -23,765,000 | |
| -22,902,000 | |
| -26,021,000 | |
| -17,621,000 | |
| -15,372,000 | |
| -13,855,000 | |
| -10,417,000 | |
| -18,017,000 | |
| -18,208,000 | |
| -19,483,000 | |
| -17,643,000 | |
| -18,022,000 | |
| -28,367,000 | |
| -30,010,000 | |
| -30,422,000 | |
| -10,618,000 | |
| -2,727,000 | |
| -5,988,000 | |
| -10,989,000 | |
| -34,238,000 | |
| -40,172,000 | |
| -42,103,000 | |
| -44,915,000 | |
| -52,199,000 | |
| -49,452,000 | |
| -49,820,000 | |
| -48,160,000 | |
| -43,619,000 | |
| -45,264,000 | |
| -46,377,000 | |
| -42,869,000 | |
| -40,597,000 | |
| -37,474,000 | |
| -31,625,000 | |
| -28,908,000 | |
| -25,605,000 | |
| -21,787,000 | |
| -21,409,000 | |
| -20,963,000 | |
| -19,964,000 | |
| -19,212,000 | |
| -16,526,000 | |
| -14,668,000 | |
| -12,368,000 | |
| -11,192,000 | |
| -10,840,000 | |
| -10,257,000 | |
| -11,676,000 | |
| -12,483,000 | |
| -11,541,000 | |
| -11,769,000 | |
| -11,216,000 | |
| -10,531,000 | |
| -10,433,000 | |
| -9,429,000 | |
| -8,886,000 | |
| -8,669,000 | |
| -6,651,000 | |
| -6,047,000 | |
| -4,141,000 |